Research Article
A Multiobjective Model for a Multilevel Blood Supply Chain to Improve the Attractiveness of Blood Centers during the COVID-19 Pandemic
Table 2
Specifications of the samples.
| Indicators | Sample instance number | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| Ordinary donor group | 2 | 4 | 6 | 8 | 10 | 14 | 16 | 18 | 19 | 20 | Improved donor group | 2 | 4 | 6 | 8 | 10 | 14 | 16 | 18 | 15 | 18 | Temporary facilities | 3 | 5 | 7 | 9 | 11 | 8 | 7 | 9 | 7 | 8 | Local centers | 4 | 6 | 8 | 10 | 12 | 9 | 8 | 10 | 12 | 10 | Regional centers | 4 | 6 | 8 | 10 | 12 | 9 | 8 | 10 | 9 | 14 | Hospitals | 2 | 4 | 6 | 8 | 10 | 8 | 7 | 10 | 12 | 15 | Blood product | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | Life of each product | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | Blood collection method | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | Period | 1 | 1 | 2 | 2 | 1 | 3 | 2 | 2 | 2 | 1 | Corona status scenarios | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 1 | 2 | 2 |
|
|